NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1174575047 MD
Verify on CMS → John Fouts, MD
Pulmonary Disease Physician in Fort Wayne, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
475
Medicare Part D claims · 88 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
11%
generic claims · 89% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.2/100
▼ 2 pts below national avg 83.5 · Above neutral
Industry payments
$13.08
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
John Fouts, MD reported a CMS MIPS final score of 81.2/100 - below the 83.5 national average - and filed 475 Medicare Part D claims in 2024.
- 81.2/100
- MIPS score · -2 vs avg
- 475
- Part D claims, 2024
- 11%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about John Fouts, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174575047), first enumerated 05/17/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 475 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 81.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$13.08 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1174575047 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1174575047
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- MIPS-INLINE 81.2/100
- RX-LIGHT 475
- BOOK-THIN 156 in Indiana
- PHOTO-FINISH Robert Sibilia · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Fouts · this pro…
Fouts · this provider
81.2 MIPS pts
- Ankur Sinha · near
Ankur Sinha
81.2 MIPS pts
- Robert Sibilia ·…
Robert Sibilia
81.2 MIPS pts
- Hima Kona · high…
Hima Kona
81.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
John Fouts, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
81 ≥ 32nd percentile 32% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where John Fouts, MD sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, John Fouts, MD writes more Part D claims than 32% of them and scores higher on MIPS quality than 36% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is John Fouts, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
John Fouts, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about John Fouts, MD?
Near national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
475 68% vs specialty avg
MIPS final score
81.2/100 2.3 pts vs avg
Specialty distribution in Indiana
How Pulmonary Disease Physician compares to other specialties among Indiana providers
Medicare quality performance, MIPS
John Fouts, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 81.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174575047 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/17/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
81.234
Final Score
Measured-score avg: 83.5
68.9532
Quality
68.4936
Cost
100
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for John Fouts, MD. Source: openpaymentsdata.cms.gov.
Total received
$13
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
John Fouts, MD - brand share 89.0%
Pulmonary Disease Physician average
89% brand-name claims vs 11% generic, on 475 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
475
Total Claims
$227K
Total Drug Cost
88
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 602.6
- Total Day Supply
- 17,218
- Brand vs Generic
- 89% brand / 11% generic
- Brand Drug Cost
- $220K
- Generic Drug Cost
- $7K
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 1.76
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 14, 65-74: 40, 75-84: 22, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What John Fouts, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Trelegy Ellipta
Trelegy Ellipta
185 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
105 claims
- Breo Ellipta 42
Breo Ellipta
42 claims
- Anoro Ellipta 24
Anoro Ellipta
24 claims
- Arnuity Ellipta 20
Arnuity Ellipta
20 claims
- Breztri Aerosphere 16
Breztri Aerosphere
16 claims
- Montelukast Sodium 11
Montelukast Sodium
11 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 185 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 105 |
| Breo Ellipta Fluticasone/Vilanterol | 42 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 24 |
| Arnuity Ellipta Fluticasone Furoate | 20 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 16 |
| Montelukast Sodium | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How John Fouts, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
John Fouts, MD's 475 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Fouts, both outside Indiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (81.2 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Fouts.
One of 156 Pulmonary Disease Physician providers enrolled in Indiana, 5 are shown here.
Dr. Mohamed Abou-Rayan
MD
Bloomington, IN
Mirza Abu Sayeem
MBBS
Marion, IN
Dr. Ismail Al-Ani
MD
South Bend, IN
Dr. Mohannad Al-Khateeb
MD
Evansville, IN
Dr. Mazen Alakhras
MD
Lafayette, IN
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is John Fouts, MD's specialty? ▼
John Fouts, MD specializes in Pulmonary Disease Physician and practices in Fort Wayne, Indiana. Credentials: MD.
How much does John Fouts, MD prescribe under Medicare Part D? ▼
In 2024, John Fouts, MD wrote 475 Medicare Part D claims totaling $227K in drug costs for 88 beneficiaries.
What is John Fouts, MD's Medicare quality score? ▼
John Fouts, MD has a CMS MIPS Final Score of 81.2/100 (Quality: 69, Cost: 68.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is John Fouts, MD located? ▼
John Fouts, MD is located at 11104 PARKVIEW CIRCLE DR STE 10, Fort Wayne, IN, 46845. Phone: (260) 266-7856.
What is John Fouts, MD's NPI number? ▼
John Fouts, MD's National Provider Identifier (NPI) is 1174575047, issued on 05/17/2006.
Does John Fouts, MD prescribe more brand-name or generic drugs? ▼
John Fouts, MD's prescribing is 89% brand-name and 11% generic drugs by claim count, with $220K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does John Fouts, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, John Fouts, MD's most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Breo Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does John Fouts, MD accept Medicare? ▼
John Fouts, MD appears in CMS Medicare data with 475 Part D claims and 88 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Fouts, MD's credentials? ▼
John Fouts, MD's NPI is 1174575047 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.